• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cdk5 复合物与 p35 和 p39 激活剂之间稳定性和活性差异的结构基础。

Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators.

机构信息

From the Department of Biological Sciences, Tokyo Metropolitan University, Minami-osawa, Hachioji, Tokyo 192-0397.

Celestar Lexico-Sciences, Inc., Nakase, Mihama-ku, Chiba 261-8501.

出版信息

J Biol Chem. 2013 Nov 8;288(45):32433-32439. doi: 10.1074/jbc.M113.512293. Epub 2013 Sep 30.

DOI:10.1074/jbc.M113.512293
PMID:24085300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3820878/
Abstract

Cyclin-dependent kinase 5 (Cdk5) is a brain-specific membrane-bound protein kinase that is activated by binding to the p35 or p39 activator. Previous studies have focused on p35-Cdk5, and little is known regarding p39-Cdk5. The lack of functional understanding of p39-Cdk5 is due, in part, to the labile property of p39-Cdk5, which dissociates and loses kinase activity in nonionic detergent conditions. Here we investigated the structural basis for the instability of p39-Cdk5. p39 and p35 contain N-terminal p10 regions and C-terminal Cdk5 activation domains (AD). Although p35 and p39 show higher homology in the C-terminal AD than the N-terminal region, the difference in stability is derived from the C-terminal AD. Based on the crystal structures of the p25 (p35 C-terminal region including AD)-Cdk5 complex, we simulated the three-dimensional structure of the p39 AD-Cdk5 complex and found differences in the hydrogen bond network between Cdk5 and its activators. Three amino acids of p35, Asp-259, Asn-266, and Ser-270, which are involved in hydrogen bond formation with Cdk5, are changed to Gln, Gln, and Pro in p39. Because these three amino acids in p39 do not participate in hydrogen bond formation, we predicted that the number of hydrogen bonds between p39 and Cdk5 was reduced compared with p35 and Cdk5. Using substitution mutants, we experimentally validated that the difference in the hydrogen bond network contributes to the different properties between Cdk5 and its activators.

摘要

周期蛋白依赖性激酶 5(Cdk5)是一种脑特异性膜结合蛋白激酶,通过与 p35 或 p39 激活剂结合而被激活。以前的研究集中在 p35-Cdk5 上,而对于 p39-Cdk5 知之甚少。缺乏对 p39-Cdk5 的功能理解部分归因于 p39-Cdk5 的不稳定性,即在非离子洗涤剂条件下解离并失去激酶活性。在这里,我们研究了 p39-Cdk5 不稳定性的结构基础。p39 和 p35 包含 N 端 p10 区域和 C 端 Cdk5 激活结构域(AD)。尽管 p35 和 p39 在 C 端 AD 中比 N 端区域具有更高的同源性,但稳定性的差异来自 C 端 AD。基于 p25(包括 AD 的 p35 C 端区域)-Cdk5 复合物的晶体结构,我们模拟了 p39 AD-Cdk5 复合物的三维结构,并发现了 Cdk5 与其激活剂之间氢键网络的差异。参与与 Cdk5 形成氢键的 p35 的三个氨基酸,天冬氨酸 259、天冬酰胺 266 和丝氨酸 270,在 p39 中分别变为谷氨酰胺、谷氨酰胺和脯氨酸。由于 p39 中的这三个氨基酸不参与氢键形成,我们预测 p39 与 Cdk5 之间氢键的数量与 p35 和 Cdk5 相比减少了。使用取代突变体,我们通过实验验证了氢键网络的差异导致了 Cdk5 与其激活剂之间的不同性质。

相似文献

1
Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators.Cdk5 复合物与 p35 和 p39 激活剂之间稳定性和活性差异的结构基础。
J Biol Chem. 2013 Nov 8;288(45):32433-32439. doi: 10.1074/jbc.M113.512293. Epub 2013 Sep 30.
2
Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35.细胞周期蛋白依赖性激酶5(Cdk5)–p39是一种不稳定的复合物,其底物特异性与Cdk5–p35相似。
J Neurochem. 2007 Sep;102(5):1477-1487. doi: 10.1111/j.1471-4159.2007.04505.x. Epub 2007 Mar 29.
3
p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.p39 是少突胶质细胞中细胞周期蛋白依赖性激酶 5(Cdk5)的主要激活剂,对于少突胶质细胞分化和髓鞘修复至关重要。
J Biol Chem. 2013 Jun 21;288(25):18047-57. doi: 10.1074/jbc.M113.453688. Epub 2013 May 3.
4
p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.p39在出生后神经元分化过程中负责增加Cdk5活性,并调控神经网络形成和癫痫反应。
J Neurosci. 2016 Nov 2;36(44):11283-11294. doi: 10.1523/JNEUROSCI.1155-16.2016.
5
Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes.p39和p35的肉豆蔻酰化是活性细胞周期蛋白依赖性激酶5复合物在细胞质或细胞核定位的决定因素。
J Neurochem. 2008 Aug;106(3):1325-36. doi: 10.1111/j.1471-4159.2008.05500.x. Epub 2008 May 26.
6
Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39.膜结合促进细胞周期蛋白依赖性激酶 5 激活剂 p35 和 p39 的降解和切割。
Biochemistry. 2010 Jul 6;49(26):5482-93. doi: 10.1021/bi100631f.
7
Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.细胞周期蛋白依赖性激酶5(Cdk5)在酪氨酸15位点的磷酸化受Cdk5激活剂抑制,且对Cdk5的激活无作用。
J Biol Chem. 2014 Jul 11;289(28):19627-36. doi: 10.1074/jbc.M113.501148. Epub 2014 May 28.
8
The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.通过p35或p39 Cdk5激活剂的代谢对细胞周期蛋白依赖性激酶5活性的调节。
Neurosignals. 2003 Sep-Oct;12(4-5):221-9. doi: 10.1159/000074624.
9
Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.Cdk5 对 p35 和 p39 的磷酸化以磷酸化位点特异性的方式决定了全激酶的亚细胞定位。
J Cell Sci. 2012 Jul 15;125(Pt 14):3421-9. doi: 10.1242/jcs.100503. Epub 2012 Mar 30.
10
Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia.p39激活的Cdk5对Rac1诱导的片状伪足的优先靶向作用。
Mol Cell Neurosci. 2014 Jul;61:34-45. doi: 10.1016/j.mcn.2014.05.006. Epub 2014 May 27.

引用本文的文献

1
A Retrospective Tribute to Dr. Harish Pant (1938-2023) and His Seminal Work on Cyclin Dependent Kinase 5.纪念哈里斯·潘特博士(1938-2023)及其在细胞周期蛋白依赖性激酶 5 方面开创性工作的回顾
Neurochem Res. 2024 Dec;49(12):3181-3186. doi: 10.1007/s11064-024-04234-5. Epub 2024 Sep 5.
2
Maintaining Drosha expression with Cdk5 inhibitors as a potential therapeutic strategy for early intervention after TBI.用 Cdk5 抑制剂维持 Drosha 的表达,作为 TBI 后早期干预的潜在治疗策略。
Exp Mol Med. 2024 Feb;56(1):210-219. doi: 10.1038/s12276-023-01152-4. Epub 2024 Jan 10.
3
Valproic Acid-Induced Anxiety and Depression Behaviors are Ameliorated in p39 Cdk5 Activator-Deficient Mice.丙戊酸诱导的焦虑和抑郁行为在 p39 Cdk5 激活剂缺陷型小鼠中得到改善。
Neurochem Res. 2022 Sep;47(9):2773-2779. doi: 10.1007/s11064-022-03642-9. Epub 2022 Jun 8.
4
Ubiquitin ligase activity inhibits Cdk5 to control axon termination.泛素连接酶活性抑制 Cdk5 以控制轴突末端。
PLoS Genet. 2022 Apr 14;18(4):e1010152. doi: 10.1371/journal.pgen.1010152. eCollection 2022 Apr.
5
Protocols for Characterization of Cdk5 Kinase Activity.Cdk5 激酶活性的表征方案。
Curr Protoc. 2021 Oct;1(10):e276. doi: 10.1002/cpz1.276.
6
Hypoxia induces HT-22 neuronal cell death via Orai1/CDK5 pathway-mediated Tau hyperphosphorylation.缺氧通过Orai1/CDK5途径介导的Tau蛋白过度磷酸化诱导HT-22神经元细胞死亡。
Am J Transl Res. 2019 Dec 15;11(12):7591-7603. eCollection 2019.
7
Peripheral and orofacial pain sensation is unaffected by the loss of p39.周围性和口腔面部疼痛感觉不受 p39 缺失的影响。
Mol Pain. 2017 Jan-Dec;13:1744806917737205. doi: 10.1177/1744806917737205.
8
Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.细胞周期蛋白依赖性激酶5(Cdk5)在酪氨酸15位点的磷酸化受Cdk5激活剂抑制,且对Cdk5的激活无作用。
J Biol Chem. 2014 Jul 11;289(28):19627-36. doi: 10.1074/jbc.M113.501148. Epub 2014 May 28.

本文引用的文献

1
Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.失调的 Cdk5 活性参与诱导阿尔茨海默病。
Arch Med Res. 2012 Nov;43(8):655-62. doi: 10.1016/j.arcmed.2012.10.015. Epub 2012 Nov 7.
2
Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.Cdk5 对 p35 和 p39 的磷酸化以磷酸化位点特异性的方式决定了全激酶的亚细胞定位。
J Cell Sci. 2012 Jul 15;125(Pt 14):3421-9. doi: 10.1242/jcs.100503. Epub 2012 Mar 30.
3
Cdk5: a multifaceted kinase in neurodegenerative diseases.Cdk5:神经退行性疾病中的多功能激酶。
Trends Cell Biol. 2012 Mar;22(3):169-75. doi: 10.1016/j.tcb.2011.11.003. Epub 2011 Dec 20.
4
Cyclin-dependent kinases in brain development and disease.细胞周期蛋白依赖性激酶在脑发育和疾病中的作用。
Annu Rev Cell Dev Biol. 2011;27:465-91. doi: 10.1146/annurev-cellbio-092910-154023. Epub 2011 Jul 5.
5
Regulation and role of cyclin-dependent kinase activity in neuronal survival and death.细胞周期蛋白依赖性激酶活性在神经元存活和死亡中的调节和作用。
J Neurochem. 2010 Dec;115(6):1309-21. doi: 10.1111/j.1471-4159.2010.07050.x. Epub 2010 Nov 4.
6
Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39.膜结合促进细胞周期蛋白依赖性激酶 5 激活剂 p35 和 p39 的降解和切割。
Biochemistry. 2010 Jul 6;49(26):5482-93. doi: 10.1021/bi100631f.
7
Suppression of mutant Huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability.Cdk5/p35通过对微管稳定性的影响抑制突变型亨廷顿蛋白聚集体的形成。
J Neurosci. 2008 Aug 27;28(35):8747-55. doi: 10.1523/JNEUROSCI.0973-08.2008.
8
Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes.p39和p35的肉豆蔻酰化是活性细胞周期蛋白依赖性激酶5复合物在细胞质或细胞核定位的决定因素。
J Neurochem. 2008 Aug;106(3):1325-36. doi: 10.1111/j.1471-4159.2008.05500.x. Epub 2008 May 26.
9
Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35.细胞周期蛋白依赖性激酶5(Cdk5)–p39是一种不稳定的复合物,其底物特异性与Cdk5–p35相似。
J Neurochem. 2007 Sep;102(5):1477-1487. doi: 10.1111/j.1471-4159.2007.04505.x. Epub 2007 Mar 29.
10
Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicity.通过质谱法绘制的亨廷顿蛋白磷酸化位点。对切割和毒性的调节。
J Biol Chem. 2006 Aug 18;281(33):23686-97. doi: 10.1074/jbc.M513507200. Epub 2006 Jun 16.